Aytu BioPharma Cash from Financing (TTM) Analysis

Aytu BioPharma Inc (AYTU)

3.10 +0.04 (+1.31%) USD | NASDAQ | May 08, 16:00

3.15 +0.05 (+1.61%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	-5.681M
September 30, 2023	-7.42M
June 30, 2023	8.871M
March 31, 2023	13.16M
December 31, 2022	12.10M
September 30, 2022	20.55M
June 30, 2022	1.53M
March 31, 2022	14.46M
December 31, 2021	6.542M
September 30, 2021	27.03M
June 30, 2021	30.31M
March 31, 2021	12.13M
December 31, 2020	86.71M
September 30, 2020	68.89M
June 30, 2020	71.07M
March 31, 2020	77.56M

Date	Value
December 31, 2019	9.633M
September 30, 2019	19.08M
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018	22.66M
March 31, 2018	22.75M
December 31, 2017	12.41M
September 30, 2017	20.02M
June 30, 2017	10.19M
March 31, 2017	16.74M
December 31, 2016	15.00M
September 30, 2016	12.39M
June 30, 2016	16.66M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-7.42M

Minimum

Sep 2023

86.71M

Maximum

Dec 2020

25.92M

Average

13.81M

Median

Cash from Financing (TTM) Benchmarks